These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

73 related items for PubMed ID: 17243925

  • 1. Analytical validation of the new version of the Liaison N-Tact PTH assay.
    Cavalier E, Delanaye P, Carlisi A, Krzesinski JM, Chapelle JP.
    Clin Chem Lab Med; 2007; 45(1):105-7. PubMed ID: 17243925
    [Abstract] [Full Text] [Related]

  • 2. Comparison of Liaison N-tact PTH (Diasorin) and N-tact PTH SP IRMA (Diasorin) in hemodialyzed patients.
    Cavalier E, Delanaye P, Krzesinski JM, Chapelle JP.
    Clin Chem Lab Med; 2005; 43(8):890-1. PubMed ID: 16201903
    [No Abstract] [Full Text] [Related]

  • 3. Higher parathyroid hormone (PTH) concentrations with the Architect PTH assay than with the Elecsys assay in hemodialysis patients, and a simple way to standardize these two methods.
    Monge M, Jean G, Bacri JL, Lemaitre V, Masy E, Joly D, Souberbielle JC.
    Clin Chem Lab Med; 2009; 47(3):362-6. PubMed ID: 19199835
    [Abstract] [Full Text] [Related]

  • 4. Multicenter evaluation of a new immunoassay for intact PTH measurement on the Elecsys System 2010 and 1010.
    Hermsen D, Franzson L, Hoffmann JP, Isaksson A, Kaufman JM, Leary E, Müller C, Nakatsuka K, Nishizawa Y, Reinauer H, Riesen W, Roth HJ, Steinmüller T, Troch T, Bergmann P.
    Clin Lab; 2002; 48(3-4):131-41. PubMed ID: 11934215
    [Abstract] [Full Text] [Related]

  • 5. Switching between parathormone (PTH) assays: the impact on the diagnosis of renal osteodystrophy.
    Bekő G, Butz H, Berta K, Tislér A, Olajos F, Vásárhelyi B, Patócs A.
    Clin Chem Lab Med; 2013 Jun; 51(6):1251-6. PubMed ID: 23241601
    [Abstract] [Full Text] [Related]

  • 6. Novel electrochemiluminescence immunoassay exclusively for full-length parathyroid hormone during treatment with cinacalcet for secondary hyperparathyroidism.
    Tanaka H, Komaba H, Koizumi M, Kakuta T, Fukagawa M.
    Ther Apher Dial; 2011 Jun; 15 Suppl 1():56-61. PubMed ID: 21595854
    [Abstract] [Full Text] [Related]

  • 7. Comparison of Two Parathyroid Hormone Assays in Hemodialysis Patients.
    Donati G, Cianciolo G, Capelli I, Baraldi O, Gambaretto C, Demelas V, Marchetti A, La Manna G.
    Artif Organs; 2016 Oct; 40(10):1013-1016. PubMed ID: 26670936
    [Abstract] [Full Text] [Related]

  • 8. [Intact whole bioactive parathormone: problems arising from comparing different methods].
    Marangella M, Migliardi M, Dutto F, Mengozzi G, Marranca D, Bagnis C, Berutti S, Gallone G, Aimo G, Ramello A, Fonzo D.
    G Ital Nefrol; 2002 Oct; 19(4):467-75. PubMed ID: 12369051
    [Abstract] [Full Text] [Related]

  • 9. Standardization of DiaSorin and Roche automated third generation PTH assays with an International Standard: impact on clinical populations.
    Cavalier E, Delanaye P, Lukas P, Carlisi A, Gadisseur R, Souberbielle JC.
    Clin Chem Lab Med; 2014 Aug; 52(8):1137-41. PubMed ID: 24670360
    [Abstract] [Full Text] [Related]

  • 10. Establishment of reference values in a healthy population and interpretation of serum PTH concentrations in hemodialyzed patients according to the KDIGO Guidelines using the Lumipulse® G whole PTH (3rd generation) assay.
    Cavalier E, Salsé M, Dupuy AM, Bargnoux AS, Watar F, Souberbielle JC, Delanaye P, Cristol JP.
    Clin Biochem; 2018 Apr; 54():119-122. PubMed ID: 29501417
    [Abstract] [Full Text] [Related]

  • 11. Trueness, precision and stability of the LIAISON 1-84 parathyroid hormone (PTH) third-generation assay: comparison to existing intact PTH assays.
    Valcour A, Zierold C, Blocki FA, Hawkins DM, Martin KJ, Rao SD, Bonelli F.
    Clin Chem Lab Med; 2018 Aug 28; 56(9):1476-1482. PubMed ID: 29750642
    [Abstract] [Full Text] [Related]

  • 12. The third/second generation PTH assay ratio as a marker for parathyroid carcinoma: evaluation using an automated platform.
    Cavalier E, Betea D, Schleck ML, Gadisseur R, Vroonen L, Delanaye P, Daly AF, Beckers A.
    J Clin Endocrinol Metab; 2014 Mar 28; 99(3):E453-7. PubMed ID: 24423313
    [Abstract] [Full Text] [Related]

  • 13. Comparison of the Elecsys PTH(1-84) assay with four contemporary second generation intact PTH assays and association with other biomarkers in chronic kidney disease patients.
    Tan K, Ong L, Sethi SK, Saw S.
    Clin Biochem; 2013 Jun 28; 46(9):781-6. PubMed ID: 23384535
    [Abstract] [Full Text] [Related]

  • 14. [Preanalytical variability of parathyroid hormone measurement in dialysis patients; application to Elecsys 2010 (Roche) automate].
    Parent X, Alenabi F, Etienne E, Brignon P, Chantrel F, Meynaud-Kraemer L.
    Ann Biol Clin (Paris); 2008 Jun 28; 66(1):53-8. PubMed ID: 18227004
    [Abstract] [Full Text] [Related]

  • 15. Development of a scintillation proximity assay for high-throughput measurement of intact parathyroid hormone.
    Frolik CA, Black EC, Chandrasekhar S, Adrian MD.
    Anal Biochem; 1998 Dec 15; 265(2):216-24. PubMed ID: 9882395
    [Abstract] [Full Text] [Related]

  • 16. Evaluation of a chemiluminescence immunoassay for the determination of intact parathyroid hormone using the ADVIA Centaur.
    Amal L, Bergmann P.
    Clin Lab; 2004 Dec 15; 50(11-12):695-702. PubMed ID: 15575312
    [Abstract] [Full Text] [Related]

  • 17. Concurrent evaluation of PTH in hemodialysis patients using N-tact-IRMA and third generation Liaison 1-84 PTH (DiaSorin).
    Benchetrit S, Green J, Bernheim J, Golan E, Zitman-Gal T.
    Clin Biochem; 2013 Mar 15; 46(4-5):395-6. PubMed ID: 23262403
    [No Abstract] [Full Text] [Related]

  • 18. Novel parathyroid hormone (1-84) assay as basis for parathyroid hormone monitoring in renal hyperparathyroidism.
    Kaczirek K, Prager G, Riss P, Wunderer G, Asari R, Scheuba C, Bieglmayer C, Niederle B.
    Arch Surg; 2006 Feb 15; 141(2):129-34; discussion 134. PubMed ID: 16490888
    [Abstract] [Full Text] [Related]

  • 19. [PTH measurement: where do we stand?].
    Marangella M.
    G Ital Nefrol; 2009 Feb 15; 26(5):600-7. PubMed ID: 19802805
    [Abstract] [Full Text] [Related]

  • 20. Current parathyroid hormone immunoassays do not adequately meet the needs of patients with chronic kidney disease.
    Almond A, Ellis AR, Walker SW, Scottish Clinical Biochemistry Managed Diagnostic Network.
    Ann Clin Biochem; 2012 Jan 15; 49(Pt 1):63-7. PubMed ID: 22096021
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.